Journal article
A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19
- Abstract:
-
Background No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2.
Methods We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection, which causes the respiratory illness Covid-19, and an oxygen saturation (Sao2) of 94% or less while they were breathing ambient air or a ratio of the partial pressure of oxygen (Pao2) to the fracti...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Wellcome Trust
More from this funder
Bibliographic Details
- Publisher:
- Massachusetts Medical Society Publisher's website
- Journal:
- New England Journal of Medicine Journal website
- Volume:
- 382
- Issue:
- 19
- Pages:
- 1787-1799
- Publication date:
- 2020-03-18
- DOI:
- EISSN:
-
1533-4406
- ISSN:
-
0028-4793
- Pmid:
-
32187464
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1095098
- Local pid:
- pubs:1095098
- Deposit date:
- 2020-06-03
Terms of use
- Copyright holder:
- Massachusetts Medical Society
- Copyright date:
- 2020
- Rights statement:
- Copyright © 2020 Massachusetts Medical Society.
If you are the owner of this record, you can report an update to it here: Report update to this record